CDT Equity, Inc. (CDT)
0.6384
-0.05
(-7.48%)
USD |
NASDAQ |
Feb 26, 13:36
CDT Equity Research and Development Expense (Quarterly) : 1.532M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| LENZ Therapeutics, Inc. | 3.791M |
| Liminatus Pharma, Inc. | 0.00 |
| Oruka Therapeutics, Inc. | 28.99M |
| Maze Therapeutics, Inc. | 25.19M |
| MapLight Therapeutics, Inc. | 26.96M |